| scholarly article | Q13442814 |
| P50 | author | Drosos E. Karageorgopoulos | Q54297342 |
| Matthew E. Falagas | Q87082633 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 1121-2; author reply 1122 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology | |
| P478 | volume | 46 |
| Q36435455 | A new metric of antibiotic class resistance in gram-negative bacilli isolated from hospitalized children |
| Q33882361 | Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients. |
| Q39062989 | Antibiotic Resistant Superbugs: Assessment of the Interrelationship of Occurrence in Clinical Settings and Environmental Niches. |
| Q34699065 | Antimicrobial Resistance in Pseudomonas sp. Causing Infections in Trauma Patients: A 6 Year Experience from a South Asian Country |
| Q58589290 | Antimicrobial Survey of Local Herbal Drugs against Isolated from Patients Admitted to a Level-I Trauma Center |
| Q34650225 | Antimicrobial activity and clinical effectiveness of sisomicin: an evaluation of the literature (1995-2011). |
| Q41004268 | Antimicrobial potentials of Helicteres isora silver nanoparticles against extensively drug-resistant (XDR) clinical isolates of Pseudomonas aeruginosa |
| Q54377510 | Antimicrobial susceptibility of intra-abdominal gram-negative bacilli from Europe: SMART Europe 2008. |
| Q92293429 | Bacteremia in febrile cancer patients in Uganda |
| Q40789543 | Blood stream infections due to multidrug-resistant organisms among spinal cord-injured patients, epidemiology over 16 years and associated risks: a comparative study |
| Q36037500 | Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what? |
| Q42240855 | Carbapenem de-escalation therapy in a resource-limited setting |
| Q64248446 | Cephalosporin resistance in community acquired spontaneous bacterial peritonitis |
| Q33890690 | Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates |
| Q37307919 | Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital |
| Q62490371 | Colonization with Multidrug-Resistant Enterobacteriaceae is Associated with Increased Mortality Following Burn Injury in Sub-Saharan Africa |
| Q92354062 | Comparative Structural Analysis of Different Mycobacteriophage-Derived Mycolylarabinogalactan Esterases (Lysin B) |
| Q90437852 | Computational screening of antimicrobial peptides for Acinetobacter baumannii |
| Q46743417 | Effectiveness of Chinese Herbal Medicine Combined with Antibiotics for Extensively Drug-Resistant Enterobacteria and Nonfermentative Bacteria Infection: Real-Life Experience in a Retrospective Cohort. |
| Q64891171 | Efflux pump inhibitors for bacterial pathogens: From bench to bedside. |
| Q84613989 | Emerging multidrug-resistant microorganisms among travelers returning to France and persons repatriated from foreign hospitals |
| Q44632510 | Epidemiology and clinical features of community-onset Acinetobacter baumannii infections |
| Q53707227 | Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections. |
| Q37134609 | Expression, crystallization and preliminary X-ray crystallographic analysis of alanine racemase from Acinetobacter baumannii OXA-23 |
| Q99634804 | Extended-Spectrum β-Lactamase-Producing Enterobacterales Shedding by Dogs and Cats Hospitalized in an Emergency and Critical Care Department of a Veterinary Teaching Hospital |
| Q92876733 | Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Neonatal Foals: Prevalence, Risk Factors for Shedding and Association with Infection |
| Q89698074 | Extended-Spectrum β-lactamase-Producing Enterobacteriaceae Shedding in Farm Horses Versus Hospitalized Horses: Prevalence and Risk Factors |
| Q84061280 | Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients |
| Q44136173 | Factors associated with recovery of multidrug-resistant bacteria in a combat support hospital in Iraq |
| Q43662701 | Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria |
| Q37869910 | Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. |
| Q42740168 | High levels of antimicrobial resistance at a tertiary trauma care centre of India. |
| Q89537696 | How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections |
| Q34227180 | Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. |
| Q36912403 | Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates |
| Q38086340 | Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence. |
| Q36298237 | Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia. |
| Q53424473 | Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection. |
| Q36887890 | In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance. |
| Q35076951 | In Vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii |
| Q43043945 | In the quest of drugs for bad bugs: are newer fluoroquinolones any better? |
| Q34483679 | In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods |
| Q41972475 | In vitro antimicrobial susceptibility to isepamicin of 6,296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece. |
| Q42695527 | In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii |
| Q56791632 | Increase in Chlorhexidine Minimal Inhibitory Concentration of Acinetobacter baumannii Clinical Isolates after Implementation of Advanced Source Control |
| Q33892585 | Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation |
| Q36172460 | Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. |
| Q54339593 | Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA). |
| Q36229076 | Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric Patients |
| Q54330643 | Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals. |
| Q40190095 | Molecular Study of Acinetobacter baumannii Isolates for Metallo-β-Lactamases and Extended-Spectrum-β-Lactamases Genes in Intensive Care Unit, Mansoura University Hospital, Egypt. |
| Q33876665 | Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan |
| Q84606138 | Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study |
| Q33711902 | Multidrug resistant Acinetobacter |
| Q37656243 | Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy |
| Q64283677 | Multidrug-resistant septicemia in neonates: A study from a teaching hospital of Northern India |
| Q35270507 | Nonconcordance with surgical site infection prevention guidelines and rates of surgical site infections for general surgical, neurological, and orthopedic procedures |
| Q36211901 | Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality. |
| Q35804736 | One cannot rule them all: Are bacterial toxins-antitoxins druggable? |
| Q40402946 | Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms |
| Q36937446 | Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa |
| Q37940546 | Pharmacokinetic and pharmacodynamic evaluation of tigecycline |
| Q64235989 | Phenotypic and Genotypic Characterization of Clinical Isolates Belonging to the (ACB) Complex Isolated From Animals Treated at a Veterinary Hospital in Switzerland |
| Q37970757 | Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy |
| Q49874670 | Population pharmacokinetics of high-dose tigecycline in patients with sepsis or septic shock. |
| Q38543852 | Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review |
| Q41997362 | Prevalence and risk factors for intestinal carriage of CTX-M-type ESBLs in Enterobacteriaceae from a Thai community. |
| Q55217082 | Prevalence of multidrug resistance, extensive drug resistance and pandrug resistance among multiple Gram-negative isolates: experience in a tertiary-care hospital ICU in North India. |
| Q58998538 | Resistance of Gram-Negative Bacilli in Lebanon |
| Q33853131 | Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units. |
| Q40177316 | Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia. |
| Q35127299 | Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy |
| Q35777207 | SecA: a potential antimicrobial target. |
| Q26995336 | Stenotrophomonas maltophilia: an emerging global opportunistic pathogen |
| Q40599520 | Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen. |
| Q84780619 | Surveillance for multidrug-resistant Acinetobacter baumannii: a lesson on definitions |
| Q93604951 | Surveillance of ESBL producing multidrug resistant in a teaching hospital in India |
| Q36529723 | Susceptibility Pattern and Distribution of Oxacillinases and bla PER-1 Genes among Multidrug Resistant Acinetobacter baumannii in a Teaching Hospital in Iran |
| Q37984504 | Susceptibility of Gram-negative bacteria to isepamicin: a systematic review |
| Q51017942 | Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. |
| Q37700555 | Treatment options for multidrug-resistant nonfermenters |
| Q92237297 | [Characteristics and Influencing Factors of Pathogenic Bacteria in Lung Cancer Chemotherapy Combined with Nosocomial Pulmonary Infection] |
| Q92922124 | [Latin American consensus to define, categorize, and report multidrug-resistant, extensively drug-resistant, or pandrug-resistant pathogensConsenso latino-americano para definição, categorização e notificação de patógenos multirresistentes, com resi |
Search more.